Icariside II is a glycosyloxyflavone that is 3,5,7-trihydroxy-4'-methoxy-8-prenylflavone in which the hydroxy group at position 3 has been converted into its alpha-L-rhamnopyranoside.
定义
Icariside II is a glycosyloxyflavone that is 3,5,7-trihydroxy-4'-methoxy-8-prenylflavone in which the hydroxy group at position 3 has been converted into its alpha-L-rhamnopyranoside. It has a role as an antineoplastic agent, an anti-inflammatory agent, an apoptosis inducer and a plant metabolite. It is functionally related to an alpha-L-rhamnopyranose.
来源: PubChem
化妆品中的作用
安全与法规参考
Other restriction: ban substances that deplete the ozone layer
来源: 欧盟 CosIng 成分清单
详细资料——标示名称、识别编号、物性、试验记录、文献
官方标示名称和定义
日本化妆品工业联合会标示名称 イカリシドⅡ: 本品は、次の化学式で表される有機化合物である。
来源: 日本化妆品工业联合会标示名称
别名和识别信息
- CAS No.化学物质登记号
- 113558-15-9
- DTXSID美国EPA化学品编号
- DTXSID40150457
- DTXCID美国EPA化合物编号
- DTXCID4072948
- IUPAC
- 5,7-Dihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-en-1-yl)-4-oxo-4H-1-benzopyran-3-yl 6-deoxy-alpha-L-mannopyranoside
- 分子式
- C27H30O10
- 分子量
- 514.527 g/mol
产品实际使用的用途
这是向美国 EPA 申报含该成分的 5 款产品的用途。其中包括化妆品以外的产品,排在前几行的即为该成分的主要用途。
- Softener and conditioner2
- Bleaching agent1
- Humectant1
- Antioxidant1
来源: 美国EPA CompTox
相关文献
- Xianling Lianxia formula enhances the inhibitory effects of trastuzumab on HER2-positive breast cancer · 2023
- Epimedium brevicornum Maxim. Extract exhibits pigmentation by melanin biosynthesis and melanosome biogenesis/transfer · 2022
- Icariside II overcomes BRAF inhibitor resistance in melanoma by inducing ROS production and inhibiting MITF. · 2020
- Blockade of epidermal growth factor receptor/mammalian target of rapamycin pathway by Icariside II results in reduced cell proliferation of osteosarcoma cells. · 2014
- Icariside II induces apoptosis via inhibition of the EGFR pathways in A431 human epidermoid carcinoma cells. · 2013